MIAN
BBH icon

Mariner Independent Advisor Network’s VanEck Biotech ETF BBH Stock Holding History

Mariner Independent Advisor Network’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,107
Closed -$251K – 194
2017
Q1 		$251K Buy
+2,107
New +$246K 0.03% 222

Other funds holding BBH

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

Mariner Independent Advisor Network's BBH Position: Q2 2017 in Review

Mariner Independent Advisor Network sold out of VanEck Biotech ETF (BBH) in Q2 2017, closing a stake of 2,107 shares — an estimated $251K sold.

Mariner Independent Advisor Network first reported a position in BBH in Q1 2017 and held it in 1 quarter. The position peaked at $251K in Q1 2017. 83 funds tracked by Wall St. Rank hold BBH as of Q2 2017.

  • Mariner Independent Advisor Network reported no remaining VanEck Biotech ETF position as of Q2 2017 after selling out during the quarter.
  • Mariner Independent Advisor Network sold 2,107 VanEck Biotech ETF shares in Q2 2017, an estimated $251K.
  • Mariner Independent Advisor Network first reported a position in VanEck Biotech ETF in Q1 2017 and held it in 1 quarter.
  • Mariner Independent Advisor Network's VanEck Biotech ETF position peaked at $251K in Q1 2017.
  • 83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2017.

Based on Mariner Independent Advisor Network's 13F filing for Q2 2017, filed 16 Aug 2017.